TFS Capital’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-42,591
Closed -$1.58M 261
2017
Q2
$1.58M Sell
42,591
-16,724
-28% -$546K 0.62% 1
2017
Q1
$1.67M Sell
59,315
-9,545
-14% -$269K 0.54% 3
2016
Q4
$2.02M Buy
68,860
+4,629
+7% +$126K 0.54% 3
2016
Q3
$1.75M Sell
64,231
-51,427
-44% -$1.16M 0.42% 43
2016
Q2
$2.16M Buy
115,658
+50,546
+78% +$1.05M 0.4% 10
2016
Q1
$1.76M Sell
65,112
-105,171
-62% -$3.02M 0.25% 99
2015
Q4
$5.13M Sell
170,283
-5,065
-3% -$163K 0.55% 31
2015
Q3
$5.55M Buy
175,348
+45,337
+35% +$1.66M 0.53% 22
2015
Q2
$5.06M Sell
130,011
-13,538
-9% -$467K 0.49% 30
2015
Q1
$5.08M Buy
143,549
+78,042
+119% +$2.51M 0.5% 24
2014
Q4
$2.07M Buy
+65,507
New +$1.81M 0.2% 134
2014
Q3
Sell
-13,932
Closed -$306K 1166
2014
Q2
$306K Buy
+13,932
New +$265K 0.02% 820

Other funds holding PAHC

TFS Capital's PAHC Position: Q3 2017 in Review

TFS Capital sold out of Phibro Animal Health (PAHC) in Q3 2017, closing a stake of 42,591 shares — an estimated $1.58M sold.

TFS Capital first reported a position in PAHC in Q2 2014 and held it in 12 quarters. The position peaked at $5.55M in Q3 2015. 164 funds tracked by Wall St. Rank hold PAHC as of Q3 2017.

  • TFS Capital reported no remaining Phibro Animal Health position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 42,591 Phibro Animal Health shares in Q3 2017, an estimated $1.58M.
  • TFS Capital first reported a position in Phibro Animal Health in Q2 2014 and held it in 12 quarters.
  • TFS Capital's Phibro Animal Health position peaked at $5.55M in Q3 2015.
  • 164 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.